#may2020mccqe1
An obese patient with a long-standing history of type 2 DM presents to his primary care physician. On examination he has decreased sensation in both lower extremities. Upon questioning of his compliance with his prescribed medications, he reports that he has stopped taking one medication because it gave him flatulence and abdominal pain. Which of the following did this man most likely stop taking?
(A) An α-glucosidase inhibitor
(B) Meglitinide
(C) Metformin
(D) Sulfonylurea
(E) Thiazolidinedione
An obese patient with a long-standing history of type 2 DM presents to his primary care physician. On examination he has decreased sensation in both lower extremities. Upon questioning of his compliance with his prescribed medications, he reports that he has stopped taking one medication because it gave him flatulence and abdominal pain. Which of the following did this man most likely stop taking?
(A) An α-glucosidase inhibitor
(B) Meglitinide
(C) Metformin
(D) Sulfonylurea
(E) Thiazolidinedione
Last edited by a moderator: